Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Moseley

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Pain and Symptom Management|June 17, 2020
Long-Term Prognosis of Older Adults Who Survive Emergency Mechanical VentilationKei Ouchi, Josephine Lo Bello, Edward Moseley, et al.
Big Data|November 18, 2015
From Pharmacovigilance to Clinical Care OptimizationLeo Anthony Celi, Edward Moseley, Christopher Moses, et al.
Plos One|April 8, 2021
Mining heterogeneous clinical notes by multi-modal latent topic modelZhi Wen, Pratheeksha Nair, Chih-Ying Deng, et al.
Plos One|June 29, 2021
Deep learning to predict long-term mortality in patients requiring 7 days of mechanical ventilationNaomi George, Edward Moseley, Rene Eber, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Comprehensive Mapping of Immune Nanobody Repertoires with NanoMAPWilliam L White, Edward Moseley, Jacqueline M Tremblay, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|June 20, 2020
Sustained maternal antibody and cellular immune responses in pregnant women infected with Zika virus and mother to infant transfer of Zika-specific antibodiesAi-Ris Y Collier, Erica N Borducchi, Abishek Chandrashekar, et al.
Journal of Pain and Symptom Management|July 16, 2021
Natural Language Processing to Identify Advance Care Planning Documentation in a Multisite Pragmatic Clinical TrialCharlotta Lindvall, Chih-Ying Deng, Edward Moseley, et al.
The Lancet. Infectious Diseases|July 4, 2020
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trialKathryn E Stephenson, Chen Sabrina Tan, Stephen R Walsh, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Pain and Symptom Management|June 17, 2020
Long-Term Prognosis of Older Adults Who Survive Emergency Mechanical VentilationKei Ouchi, Josephine Lo Bello, Edward Moseley, et al.
Big Data|November 18, 2015
From Pharmacovigilance to Clinical Care OptimizationLeo Anthony Celi, Edward Moseley, Christopher Moses, et al.
Plos One|April 8, 2021
Mining heterogeneous clinical notes by multi-modal latent topic modelZhi Wen, Pratheeksha Nair, Chih-Ying Deng, et al.
Plos One|June 29, 2021
Deep learning to predict long-term mortality in patients requiring 7 days of mechanical ventilationNaomi George, Edward Moseley, Rene Eber, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Comprehensive Mapping of Immune Nanobody Repertoires with NanoMAPWilliam L White, Edward Moseley, Jacqueline M Tremblay, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|June 20, 2020
Sustained maternal antibody and cellular immune responses in pregnant women infected with Zika virus and mother to infant transfer of Zika-specific antibodiesAi-Ris Y Collier, Erica N Borducchi, Abishek Chandrashekar, et al.
Journal of Pain and Symptom Management|July 16, 2021
Natural Language Processing to Identify Advance Care Planning Documentation in a Multisite Pragmatic Clinical TrialCharlotta Lindvall, Chih-Ying Deng, Edward Moseley, et al.
The Lancet. Infectious Diseases|July 4, 2020
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trialKathryn E Stephenson, Chen Sabrina Tan, Stephen R Walsh, et al.
Pageof 1